Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
about
Big data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicantsLeveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology.High throughput toxicity screening and intracellular detection of nanomaterialsUtilizing Zebrafish Visual Behaviors in Drug Screening for Retinal DegenerationFacile preparation of a photoactivatable surface on a 96-well plate: a versatile and multiplex cell migration assay platform.The current state of drug discovery and a potential role for NMR metabolomics.Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayersTransforming microbial genotyping: a robotic pipeline for genotyping bacterial strains.Droplet control technologies for microfluidic high throughput screening (μHTS).The virtual cell based assay: Current status and future perspectives.High throughput absorbance spectra of cancerous cells: a microscopic investigation of spectral artifacts.The role of high-throughput screening in ecotoxicology and engineered nanomaterials.Lipidomics in translational research and the clinical significance of lipid-based biomarkers.The use of natural products to target cancer stem cells.Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay.Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma.Optimization and Validation of Two High-Throughput Methods Indicating Antiradical Activity.High-throughput approaches for screening and analysis of cell behaviors.Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders.A Versatile Microarray Immobilization Strategy Based on a Biorthogonal Reaction Between Tetrazine and Trans-Cyclooctene.Doxorubicin kinetics and effects on lung cancer cell lines using in vitro Raman micro-spectroscopy: binding signatures, drug resistance and DNA repair.Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
P2860
Q27008504-E36EEA83-1D60-4835-91B9-D29BE07DDEF8Q28821886-DE968223-9376-46FC-94C8-0FAF6DF90F9AQ29248511-3E8F3FA4-C4E4-4221-95DE-C8C77D01562BQ33838630-8B034C20-E806-47D7-B9CF-938AF64147FAQ34475818-18B7E774-4E7C-463A-83F5-D56987486DAAQ35072850-1A847D8B-4358-4995-8559-45F3483D97C6Q35636332-0A3793BF-D476-4A4B-95AC-57330FE82E9BQ36353916-5213EB82-6751-482C-A1D2-0E3F644F3B6AQ38669110-6CE46608-CD10-4078-84D9-01A2AB082431Q38720318-35D417F2-E003-4074-9159-D6CF4E9D90D6Q38922210-9EA4DFA5-995B-4ECD-BA73-9A9A47162025Q39261310-71B95809-F7C1-4B16-85A7-58A98E67B04AQ39408952-FF6D5D8A-5DFF-4951-B1DE-3FA8499E2D02Q39458512-9686561E-D4F9-4E0C-BFBA-BB570DA6BB53Q40743692-D12E30C6-07F3-4642-9E84-5B6D2D7C5D60Q41573147-E2A6B46C-56D2-4019-B77D-80994357A0A2Q47185634-BC5B7058-179A-401C-A1F9-9A249CF2CBE2Q47402576-C148BBA2-28E4-4766-866D-6F0C242BBAF2Q47889903-DBB77497-2546-442B-B6C0-CC151C1F7373Q48926190-4CD0F8D2-6292-4598-A185-C7AA8C480920Q53735791-5A3D6E97-D16B-459A-B86C-4C5BCC5F5991Q54256710-FD30FD91-D1F4-4D57-9499-E745C7E0BFCC
P2860
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
@ast
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
@en
type
label
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
@ast
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
@en
prefLabel
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
@ast
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.
@en
P2860
P921
P356
P1476
Adaptation of high-throughput screening in drug discovery-toxicological screening tests
@en
P2093
Elżbieta Mikiciuk-Olasik
Magdalena Markowicz
P2860
P304
P356
10.3390/IJMS13010427
P407
P577
2011-12-29T00:00:00Z